Authors: Abdullah Al Mamun, Adil Maqbool, Saleh Mohammad Shahedul Islam, Iqbal Bahar Chowdhury, Matiur Rahman, Farzana Sohael, Arifur Rahman, Majedul Islam, Takeru Shima, Nobutake Shimojo, Satoru Kawano, Naoto Yamaguchi, Masao Moroi, Subrina Jesmin.
In December 2019, a new human coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was discovered in Wuhan, China. Since then, the virus has spread over the world, affecting over 180 nations. SARS-CoV-2 has infected people of all ages, races, and genders, infecting both men and women and spreading at an alarming pace across communities. Given the virus's origin, much remains unknown; however, we do know that clinical presentations vary from a typical cold to more serious infections, including pneumonia, bronchitis, severe acute respiratory distress syndrome (ARDS), multi-organ failure, and even death. COVID-19 is thought to have a more fast and severe progression in people with underlying health issues or co-morbidities, frequently resulting in death.
Methods: This retrospective study was conducted at Bangladesh's Tertiary care hospital. 534 patients were selected for this study. Medical history, age, gender, and co-morbidities (including Hypertension, Diabetes, and CKD, etc.) were recorded at the time of diagnosis, biochemical parameters such as CRP, ESR, creatinine, FBS, Hb, and LDH were also recorded. SARS-CoV-2 RNA was detected using a real-time reverse transcription-polymerase chain reaction (rRT-PCR) at diagnosis and throughout the follow-up of these patients.
Results: The comorbid conditions, illness progression, and death rates in patients from a Bangladeshi tertiary care hospital were investigated in this study. COVID-19 patients with co-morbidities, such as hypertension or diabetes, are more likely to have a more severe course and development of the disease. Furthermore, individuals over the age of 60 who have co-morbidities and are infected have a higher incidence of admission to the intensive care unit (ICU) and death from the COVID-19.
Conclusion: Where Vaccination, Early diagnosis, and Management lead to a better prognosis, patients with co-morbidities should take all steps to prevent contracting SARS CoV-2 since their prognosis is generally the poorest.
View/Download pdf